C
Cartesian Therapeutics, Inc. (RNAC)
NGM – Real Time Price. Currency in USD
5.85
-0.23 (-3.78%)
At close: Mar 27, 2026, 4:00 PM EDT
5.83
-0.02 (-0.34%)
After-hours: Mar 27, 2026, 4:18 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
5.85
-0.23 (-3.78%)
At close: Mar 27, 2026, 4:00 PM EDT
5.83
-0.02 (-0.34%)
After-hours: Mar 27, 2026, 4:18 PM EDT
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
| Name | Position |
|---|---|
| Dr. Carsten Brunn Ph.D. | President, CEO & Chairman of the Board |
| Dr. Emily English Ph.D. | Chief Operating Officer |
| Dr. Metin Kurtoglu M.D., Ph.D. | Consultant |
| Dr. Milos Miljkovic M.D., Ph.D. | Chief Medical Officer |
| Mr. Blaine T. Davis | Chief Financial Officer |
| Mr. Matthew Bartholomae J.D. | General Counsel & Secretary |
| Ms. June Seymour | Chief Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-03-09 | 8-K | rnac-20260309.htm |
| 2026-01-09 | 8-K | rnac-20260109.htm |
| 2025-12-18 | 8-K | rnac-20251216.htm |
| 2025-11-13 | 8-K | rnac-20251113.htm |
| 2025-11-06 | 8-K | rnac-20251106.htm |
| 2025-10-30 | 8-K | ef20057980_8k.htm |
| 2025-10-21 | 8-K | rnac-20251015.htm |
| 2025-10-08 | 8-K | rnac-20251002.htm |
| 2025-08-07 | 10-Q | rnac-20250630.htm |
| 2025-06-16 | 8-K | rnac-20250613.htm |